A KAUST team discovered a simple method to fabricate microspheres using block copolymer self-assembly. The resulting particles have pH-responsive gates and a highly porous structure, granting them ultrahigh protein sorption capacity. The team leveraged their expertise in block copolymers and self-assembly to achieve this. Why it matters: This new method and the resulting particles have potential applications in biotechnology, medicine, and catalysis, advancing materials science in the region.
The Robotics, Intelligent Systems, and Control (RISC) lab at KAUST is developing swarm robotics, enabling robots to work together on collaborative tasks with limited human supervision. RISC is using game theory to improve how robots make coordinated decisions in scenarios like engaging intruders or tracking oil spills. The lab is also researching programmable self-assembly for robot swarms. Why it matters: This research advances autonomous multi-agent systems for critical applications like search and rescue and environmental monitoring in the region.
Sami Haddadin from the Technical University of Munich (TUM) discusses a shift in robotics towards machines that autonomously develop their own blueprints and controls. He highlights advancements driven by human-centered design, soft control, and model-based machine learning, enabling human-robot collaboration in manufacturing and healthcare. Haddadin also presents progress towards autonomous machine design and modular control architectures for complex manipulation tasks. Why it matters: This research has implications for advancing robotics and AI in the GCC region, especially in manufacturing and healthcare, by enabling safer and more efficient human-robot collaboration.
Scientists at King Abdullah University of Science and Technology (KAUST) have engineered tiny metal-organic frameworks (MOFs) to deliver a team of six proteins into living cells. Inside the cells, these proteins formed a nanoscale factory that successfully produced violacein, a natural bioactive compound with therapeutic potential. This breakthrough represents the most complex multiprotein system delivered into living cells to date and the first example of a 'protein pathway transplant'. Why it matters: This research offers an early demonstration of how future therapies might generate treatment molecules directly inside the body at disease sites, potentially leading to more precise and less toxic medical interventions.